India's generic-drug trials under scrutiny
Serial testing of some volunteers and cursory checks raising new questions about the level of oversight of the industry
Hyderabad
VASUDEVA Prakash left his job as a mechanic in Hyderabad three years ago for what he calls a more lucrative career: taking part in clinical trials on generic drugs.
For two years, Mr Prakash participated in trials of drugs being tested to treat HIV/AIDS and other diseases for contract research organisations (CROs) hired by global pharmaceutical companies. The drugs tested at Indian CROs have been key in getting several hundred medicines approved for sale around the world.
Yet, Mr Prakash did not follow international guidelines for testing - and the CROs that hired him didn't require him to. He says that…
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Japan’s 7-Eleven convenience chain targets aggressive global growth
Bubble tea maker Chabaidao slumps 10% in Hong Kong’s biggest 2024 debut
Parental fury after stem cell bank ruins thousands of samples in Singapore
China’s bubble tea boom creates a half-dozen billionaires
US sues to block Coach owner’s US$8.5 billion buyout of Versace parent
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO